These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 1296285)
1. Thoughts on the proper use and interpretation of clinical pathology data in preclinical safety testing: a Canadian perspective. Mueller RW Toxicol Pathol; 1992; 20(3 Pt 2):526-7. PubMed ID: 1296285 [No Abstract] [Full Text] [Related]
2. The evolution of toxicologic pathology. Stula EF Toxicol Pathol; 1997; 25(6):658-9. PubMed ID: 9437816 [No Abstract] [Full Text] [Related]
3. Contemporary and Emerging Applications in Clinical Pathology. Aulbach AD; Jordan H; Tarrant J Toxicol Pathol; 2017 Feb; 45(2):257-259. PubMed ID: 28178897 [No Abstract] [Full Text] [Related]
4. Food and Drug Administration risk assessment--process and toxicologic pathology. Moch RW; Dua PN; Hines FA Toxicol Pathol; 1997; 25(1):61-7. PubMed ID: 9061853 [TBL] [Abstract][Full Text] [Related]
5. The role of the toxicologic pathologist in the biopharmaceutical industry. van Tongeren S; Fagerland JA; Conner MW; Diegel K; Donnelly K; Grubor B; Lopez-Martinez A; Bolliger AP; Sharma A; Tannehill-Gregg S; Turner PV; Wancket LM Int J Toxicol; 2011 Oct; 30(5):568-82. PubMed ID: 21878555 [TBL] [Abstract][Full Text] [Related]
7. Future of toxicology--mechanisms of toxicity and drug safety: where do we go from here? Stevens JL Chem Res Toxicol; 2006 Nov; 19(11):1393-401. PubMed ID: 17112225 [TBL] [Abstract][Full Text] [Related]
8. [When health threatens pathological anatomy]. Bonenfant JL Union Med Can; 1979 May; 108(5):585-7. PubMed ID: 516206 [No Abstract] [Full Text] [Related]
9. Clinical pathology for preclinical safety assessment: current global guidelines. Hall RL Toxicol Pathol; 1992; 20(3 Pt 2):472-6. PubMed ID: 1296274 [TBL] [Abstract][Full Text] [Related]
11. International Workshop on Clinical Pathology Testing in Preclinical Safety Assessment. Proceedings. Washington, D.C., July 27, 1991. Toxicol Pathol; 1992; 20(3 Pt 2):469-543. PubMed ID: 1363584 [No Abstract] [Full Text] [Related]
12. Interpretative considerations for clinical pathology findings in nonclinical toxicology studies. Aulbach A; Vitsky A; Arndt T; Ramaiah L; Logan M; Siska W; Cregar L; Tripathi N; Adedeji A; Provencher A; Gupta A; Jordan H; Bounous D; Boone L Vet Clin Pathol; 2019 Sep; 48(3):383-388. PubMed ID: 31549731 [TBL] [Abstract][Full Text] [Related]
13. Canadian Network of Toxicology Centres (CNTC) executive summary--annual research symposium, 29-30 March 1999. Ritter L; Hale B; Krishnan K; Van Der Kraak G; Warner D J Toxicol Environ Health A; 2000 Apr; 59(7):527-38. PubMed ID: 10777244 [No Abstract] [Full Text] [Related]
14. WELCAN UK: its development and future. Bennett CH J Clin Pathol; 1991 Aug; 44(8):617-20. PubMed ID: 1890192 [No Abstract] [Full Text] [Related]
15. The practice of pathology in Canada: decreasing pathologist supply and uncertain outcomes. Colgan TJ; Geldenhuys L Arch Pathol Lab Med; 2012 Jan; 136(1):90-4. PubMed ID: 22208492 [TBL] [Abstract][Full Text] [Related]
16. Patient safety: a macrosystems perspective. Dupree WB; Lin F Clin Lab Med; 2008 Jun; 28(2):189-205, v-vi. PubMed ID: 18436066 [TBL] [Abstract][Full Text] [Related]
17. [Perspective of clinical pathology/laboratory medicine in Japan]. Kawai T Rinsho Byori; 1996 May; 44(5):401-5. PubMed ID: 8676556 [TBL] [Abstract][Full Text] [Related]